13F Portfolios

Octagon Capital Advisors LP: COGENT BIOSCIENCES INC (COGT): Quarterly 13F Position History

As of Q1 2026, Octagon Capital Advisors LP reported 2,350,000 shares of COGENT BIOSCIENCES INC (COGT), worth $90.5M and representing 10.0% of its 13F equity book. The position first appeared in Q3 2024 and has been disclosed across 7 13F-HR filings in Pactolio's tracked window.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 7 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q1 2026 2,350,000 0 $90.5M 10.0% $38.5
Q4 2025 2,350,000 524,111 -18.2% $83.5M 10.5% $35.5
Q3 2025 2,874,111 +111,111 +4.0% $41.3M 6.4% $14.4
Q2 2025 2,763,000 +669,000 +31.9% $19.8M 4.4% $7.2
Q1 2025 2,094,000 669,000 -24.2% $45.8M 9.0% $21.9
Q4 2024 2,763,000 +1,458,000 +111.7% $21.6M 3.7% $7.8
Q3 2024 1,305,000 $14.1M 2.3% $10.8

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.

When did Octagon Capital Advisors LP first disclose a COGT position in 13F-HR filings?

Octagon Capital Advisors LP first reported COGENT BIOSCIENCES INC (COGT) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 7 reported quarters within Pactolio's tracked window.

What was Octagon Capital Advisors LP's most recent quarter-over-quarter share-count change in COGT?

Octagon Capital Advisors LP held the same 2,350,000 shares of COGT between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.

Does the implied price-per-share represent Octagon Capital Advisors LP's cost basis in COGT?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.